Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B3,7 | Lung | Primary cancer | 2,763 | Tumor/Malignant | 28.3% | 0.86 | 0.46 |
| NSCLC_38242124__IMC__175_B3,8 | Lung | Primary cancer | 4,496 | Tumor/Malignant | 47.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B3,9 | Lung | Primary cancer | 3,044 | Tumor/Malignant | 79.9% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B4,1 | Lung | Primary cancer | 3,046 | Tumor/Malignant | 51.1% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__175_B4,10 | Lung | Primary cancer | 1,320 | Tumor/Malignant | 27.2% | 0.75 | 0.66 |
| NSCLC_38242124__IMC__175_B4,11 | Lung | Primary cancer | 2,898 | Tumor/Malignant | 85.2% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__175_B4,12 | Lung | Primary cancer | 4,536 | Tumor/Malignant | 95.6% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__175_B4,13 | Lung | Primary cancer | 2,834 | Tumor/Malignant | 52.2% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B4,14 | Lung | Primary cancer | 3,599 | Tumor/Malignant | 42.5% | 1.00 | 0.04 |
| NSCLC_38242124__IMC__175_B4,15 | Lung | Primary cancer | 3,084 | Tumor/Malignant | 38.8% | 0.55 | 0.74 |
| NSCLC_38242124__IMC__175_B4,16 | Lung | Primary cancer | 4,218 | Tumor/Malignant | 32.7% | 0.51 | 0.73 |
| NSCLC_38242124__IMC__175_B4,17 | Lung | Primary cancer | 3,092 | Tumor/Malignant | 37.2% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B4,2 | Lung | Primary cancer | 2,911 | Tumor/Malignant | 44.2% | 0.98 | 0.10 |
| NSCLC_38242124__IMC__175_B4,3 | Lung | Primary cancer | 3,892 | Tumor/Malignant | 54.8% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__175_B4,4 | Lung | Primary cancer | 2,855 | Tumor/Malignant | 38.1% | 0.86 | 0.36 |
| NSCLC_38242124__IMC__175_B4,5 | Lung | Primary cancer | 3,190 | Tumor/Malignant | 49.8% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__175_B4,6 | Lung | Primary cancer | 3,026 | Tumor/Malignant | 48.2% | 0.94 | 0.21 |
| NSCLC_38242124__IMC__175_B4,7 | Lung | Primary cancer | 2,360 | Tumor/Malignant | 57.8% | 0.91 | 0.29 |
| NSCLC_38242124__IMC__175_B4,8 | Lung | Primary cancer | 5,430 | Tumor/Malignant | 66.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__175_B4,9 | Lung | Primary cancer | 3,378 | Tumor/Malignant | 88.0% | 1.00 | 0.02 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B3,7 | Lung | Primary cancer | 2,763 | Tumor/Malignant | 23.2% | 0.56 | 0.89 |
| NSCLC_38242124__IMC__175_B3,8 | Lung | Primary cancer | 4,496 | Tumor/Malignant | 48.3% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__175_B3,9 | Lung | Primary cancer | 3,044 | Tumor/Malignant | 63.1% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__175_B4,1 | Lung | Primary cancer | 3,046 | Tumor/Malignant | 47.5% | 0.95 | 0.18 |
| NSCLC_38242124__IMC__175_B4,10 | Lung | Primary cancer | 1,320 | Stromal | 22.7% | 0.53 | 0.91 |
| NSCLC_38242124__IMC__175_B4,11 | Lung | Primary cancer | 2,898 | Tumor/Malignant | 79.1% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__175_B4,12 | Lung | Primary cancer | 4,536 | Tumor/Malignant | 89.3% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__175_B4,13 | Lung | Primary cancer | 2,834 | Tumor/Malignant | 50.7% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__175_B4,14 | Lung | Primary cancer | 3,599 | Tumor/Malignant | 54.7% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__175_B4,15 | Lung | Primary cancer | 3,084 | Stromal | 32.8% | 0.49 | 0.77 |
| NSCLC_38242124__IMC__175_B4,16 | Lung | Primary cancer | 4,218 | Tumor/Malignant | 25.3% | 0.52 | 0.75 |
| NSCLC_38242124__IMC__175_B4,17 | Lung | Primary cancer | 3,092 | Tumor/Malignant | 39.2% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__175_B4,2 | Lung | Primary cancer | 2,911 | Tumor/Malignant | 52.9% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__175_B4,3 | Lung | Primary cancer | 3,892 | Tumor/Malignant | 57.8% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__175_B4,4 | Lung | Primary cancer | 2,855 | Tumor/Malignant | 28.4% | 0.65 | 0.69 |
| NSCLC_38242124__IMC__175_B4,5 | Lung | Primary cancer | 3,190 | Tumor/Malignant | 50.1% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__175_B4,6 | Lung | Primary cancer | 3,026 | Tumor/Malignant | 43.5% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B4,7 | Lung | Primary cancer | 2,360 | Tumor/Malignant | 47.0% | 0.95 | 0.22 |
| NSCLC_38242124__IMC__175_B4,8 | Lung | Primary cancer | 5,430 | Tumor/Malignant | 65.1% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__175_B4,9 | Lung | Primary cancer | 3,378 | Tumor/Malignant | 85.2% | 1.00 | 0.01 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__175_B3,7 | Lung | Primary cancer | 2,763 | Tumor/Malignant cell | 28.6% | 0.85 | 0.46 |
| NSCLC_38242124__IMC__175_B3,8 | Lung | Primary cancer | 4,496 | Tumor/Malignant cell | 63.0% | 0.97 | 0.16 |
| NSCLC_38242124__IMC__175_B3,9 | Lung | Primary cancer | 3,044 | Tumor/Malignant cell | 80.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__175_B4,1 | Lung | Primary cancer | 3,046 | Tumor/Malignant cell | 53.0% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__175_B4,10 | Lung | Primary cancer | 1,320 | Tumor/Malignant cell | 25.7% | 0.76 | 0.71 |
| NSCLC_38242124__IMC__175_B4,11 | Lung | Primary cancer | 2,898 | Tumor/Malignant cell | 79.7% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__175_B4,12 | Lung | Primary cancer | 4,536 | Tumor/Malignant cell | 95.7% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__175_B4,13 | Lung | Primary cancer | 2,834 | Tumor/Malignant cell | 52.4% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__175_B4,14 | Lung | Primary cancer | 3,599 | Tumor/Malignant cell | 56.8% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__175_B4,15 | Lung | Primary cancer | 3,084 | Tumor/Malignant cell | 35.6% | 0.57 | 0.82 |
| NSCLC_38242124__IMC__175_B4,16 | Lung | Primary cancer | 4,218 | Tumor/Malignant cell | 39.5% | 0.77 | 0.53 |
| NSCLC_38242124__IMC__175_B4,17 | Lung | Primary cancer | 3,092 | Tumor/Malignant cell | 43.6% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__175_B4,2 | Lung | Primary cancer | 2,911 | Tumor/Malignant cell | 58.8% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__175_B4,3 | Lung | Primary cancer | 3,892 | Tumor/Malignant cell | 57.5% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__175_B4,4 | Lung | Primary cancer | 2,855 | Tumor/Malignant cell | 38.7% | 0.85 | 0.39 |
| NSCLC_38242124__IMC__175_B4,5 | Lung | Primary cancer | 3,190 | Tumor/Malignant cell | 49.5% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__175_B4,6 | Lung | Primary cancer | 3,026 | Tumor/Malignant cell | 48.7% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__175_B4,7 | Lung | Primary cancer | 2,360 | Tumor/Malignant cell | 56.6% | 0.92 | 0.29 |
| NSCLC_38242124__IMC__175_B4,8 | Lung | Primary cancer | 5,430 | Tumor/Malignant cell | 67.1% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__175_B4,9 | Lung | Primary cancer | 3,378 | Tumor/Malignant cell | 86.0% | 1.00 | 0.01 |